Rhodium(III)-Picolinamide Complexes Act as Anticancer and Antimetastasis Agents via Inducing Apoptosis and Autophagy

被引：22

作者：

Gu, Yun-Qiong ^{[1
,2
]}

Yang, Kun ^{[1
]}

Yang, Qi-Yuan ^{[1
]}

Li, Huan-Qing ^{[1
]}

Hu, Mei-Qi ^{[1
]}

Ma, Meng-Xue ^{[1
]}

Chen, Nan-Feng ^{[1
]}

Liu, Yang-Han ^{[1
]}

Liang, Hong ^{[1
]}

Chen, Zhen-Feng ^{[1
]}

机构：

[1] Guangxi Normal Univ, Collaborat Innovat Ctr Guangxi Ethn Med, Sch Chem & Pharmaceut Sci, State Key Lab Chem & Mol Engn Med Resources, Guilin 541004, Peoples R China

[2] Nanning Normal Univ, Sch Environm & Life Sci, Nanning 530001, Peoples R China

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2023年 / 66卷 / 14期

基金：

中国国家自然科学基金;

关键词：

RHODIUM METALLOINSERTORS; FLUORESCENT-PROBE; CANCER; INHIBITION; STRESS;

D O I：

10.1021/acs.jmedchem.3c00318

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

As a continuation of our endeavors in discovering metal-baseddrugswith cytotoxic and antimetastatic activities, herein, we reportedthe syntheses of 11 new rhodium(III)-picolinamide complexesand the exploration of their potential anticancer activities. TheseRh(III) complexes showed high antiproliferative activity against thetested cancer cell lines in vitro. The mechanism study indicated that Rh1 ([Rh(3a)(CH3CN)Cl-2])and Rh2 ([Rh(3b)(CH3CN)Cl-2]) inhibited cell proliferation by multiple modes of actionvia cell cycle arrest, apoptosis, and autophagy and inhibited cellmetastasis via FAK-regulated integrin & beta;1-mediated suppressionof EGFR expression. Furthermore, Rh1 and Rh2 significantly inhibited bladder cancer growth and breast cancermetastasis in a xenograft model. These rhodium(III) complexes couldbe developed as potential anticancer agents with antitumor growthand antimetastasis activity.

引用

收藏

页码：9592 / 9606

页数：15

相关论文

共 75 条

[61] Lung squamous cell carcinoma cells express non-canonically glycosylated IgG that activates integrin-FAK signaling [J].

Tang, Jingshu ;

Zhang, Jingxuan ;

Liu, Yang ;

Liao, Qinyuan ;

Huang, Jing ;

Geng, Zihan ;

Xu, Weiyan ;

Sheng, Zhengzuo ;

Lee, Gregory ;

Zhang, Youhui ;

Chen, Jinfeng ;

Zhang, Liang ;

Qiu, Xiaoyan .

CANCER LETTERS, 2018, 430 :148-159

[62] Discovery, synthesis and molecular corroborations of medicinally important novel pyrazoles; drug efficacy determinations through in silico, in vitro and cytotoxicity validations [J].

Thangarasu, P. ;

Manikandan, A. ;

Thamaraiselvi, S. .

BIOORGANIC CHEMISTRY, 2019, 86 :410-419

[63] Restraining Cancer Cells by Dual Metabolic Inhibition with a Mitochondrion-Targeted Platinum(II) Complex [J].

Wang, Kun ;

Zhu, Chengcheng ;

He, Yafeng ;

Zhang, Zhenqin ;

Zhou, Wen ;

Muhammad, Nafees ;

Guo, Yan ;

Wang, Xiaoyong ;

Guo, Zijian .

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2019, 58 (14) :4638-4643

[64] Design, Synthesis, and Bioactivity Evaluation of Dual-Target Inhibitors of Tubulin and Src Kinase Guided by Crystal Structure [J].

Wang, Lun ;

Zheng, Yunhua ;

Li, Dan ;

Yang, Jianhong ;

Lei, Lei ;

Yan, Wei ;

Zheng, Wei ;

Tang, Minghai ;

Shi, Mingsong ;

Zhang, Ruijia ;

Cai, Xiaoying ;

Ni, Hengfan ;

Ma, Xu ;

Li, Na ;

Hong, Feng ;

Ye, Haoyu ;

Chen, Lijuan .

JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (12) :8127-8141

[65] Near infrared light fluorescence imaging-guided biomimetic nanoparticles of extracellular vesicles deliver indocyanine green and paclitaxel for hyperthermia combined with chemotherapy against glioma [J].

Wang, Meng ;

Lv, Chen-Yan ;

Li, Shu-Ang ;

Wang, Jun-Kuan ;

Luo, Wen-Zheng ;

Zhao, Pei-Chao ;

Liu, Xue-You ;

Wang, Ze-Ming ;

Jiao, Yang ;

Sun, Hong-Wei ;

Zhao, Yi ;

Zhang, Peng .

JOURNAL OF NANOBIOTECHNOLOGY, 2021, 19 (01)

[66] Reactive Oxygen Species (ROS)-Responsive Prodrugs, Probes, and Theranostic Prodrugs: Applications in the ROS-Related Diseases [J].

Wang, Pengfei ;

Gong, Qijie ;

Hu, Jiabao ;

Li, Xiang ;

Zhang, Xiaojin .

JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (01) :298-325

[67] Mitochondria-targeted half-sandwich rutheniumII diimine complexes: anticancer and antimetastasis via ROS-mediated signalling [J].

Xu, Zhishan ;

Kong, Deliang ;

He, Xiangdong ;

Guo, Lihua ;

Ge, Xingxing ;

Liu, Xicheng ;

Zhang, Hairong ;

Li, Juanjuan ;

Yang, Yuliang ;

Liu, Zhe .

INORGANIC CHEMISTRY FRONTIERS, 2018, 5 (09) :2100-2105

[68] A Rhodium(III)-Based Inhibitor of Lysine-Specific Histone Demethylase 1 as an Epigenetic Modulator in Prostate Cancer Cells [J].

Yang, Chao ;

Wang, Wanhe ;

Liang, Jia-Xin ;

Li, Guodong ;

Vellaisamy, Kasipandi ;

Wong, Chun-Yuen ;

Ma, Dik-Lung ;

Leung, Chung-Hang .

JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (06) :2597-2603

[69] Selective Inhibition of Lysine-Specific Demethylase 5A (KDM5A) Using a Rhodium(III) Complex for Triple-Negative Breast Cancer Therapy [J].

Yang, Guan-Jun ;

Wang, Wanhe ;

Mok, Simon Wing Fai ;

Wu, Chun ;

Law, Betty Yuen Kwan ;

Miao, Xiang-Min ;

Wu, Ke-Jia ;

Zhong, Hai-Jing ;

Wong, Chun-Yuen ;

Wong, Vincent Kam Wai ;

Ma, Dik-Lung ;

Leung, Chung-Hang .

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2018, 57 (40) :13091-13095

[70] Identification of a Potent Oridonin Analogue for Treatment of Triple-Negative Breast Cancer [J].

Yao, Hong ;

Xie, Shaowen ;

Ma, Xiaoqian ;

Liu, Junkai ;

Wu, Hongyu ;

Lin, Aijun ;

Yao, Hequan ;

Li, Dahong ;

Xu, Shengtao ;

Yang, Dong-Hua ;

Chen, Zhe-Sheng ;

Xu, Jinyi .

JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (15) :8157-8178

← 1 2 3 4 5 6 7 8 →